Ricovr Healthcare Announces Prominent Industry Leaders to its Advisory Board

featured-image

Advisors Include Former Chairman & CEO Of Quest Diagnostics, Former CEO Of Spirit Airlines, and Former Senior Partner Of Goldman Sachs

PRINCETON, NEW JERSEY, UNITED STATES, February 24, 2020 /EINPresswire.com/ — Ricovr Healthcare, a New Jersey-based innovative oral diagnostic company, announced the formation of the advisory board today.

The advisory board includes the following leadership: Surya N. Mohapatra, former Chairman and CEO of Quest Diagnostics (NYSE: DGX); Ben Baldanza, former CEO and president of Spirit Airlines (NYSE: SAVE); and Kevin Quinn, former Partner and co-head of Global Technology Banking at Goldman Sachs (NYSE: GS). Ricovr is developing state-of-the-art technology for oral point-of-care testing, which will benefit businesses, law enforcement officials, and the medical community.”

“We are pleased to announce distinguished business leaders to our advisory board,” said Dr. Himanshu Bhatia, Founder and CEO of Ricovr Healthcare” “We thoughtfully curated this board to include expertise across various industries such as drug testing, transportation, Hi-Tech, and government-industry advisors who will guide Ricovr on strategy and go-to-market priorities.”

“I am honored to join the advisory board of Ricovr as I believe in the company’s mission and the urgent need for innovation in the diagnostics field,” said Surya N. Mohapatra, Ph.D., Former Chairman & CEO Of Quest Diagnostics.”

“Coming from the transportation industry, I see hoRicovr’s technology can improve safety and productivity not only for Airlines but also for ground transportation operators, warehouses, security officers, and even parents,” said Ben Baldanza.”

Oral diagnostics is a fast-growing market, and Riocvr has the right technology and execution team to disrupt the industry,” said Kevin Quinn.

Ricovr Healthcare is developing a biosensor technology to manufacture and commercialize revolutionary oral point-of-care medical devices in diverse markets. The devices are expected to speed up the screening and monitoring of medical diagnostics.

About Ricovr
Dr. Himanshu Bhatia, a physician executive with a deep background in medical devices and biotechnology, founded Ricovr Healthcare. In addition, Piyush Sadana, Co-Founder, is a seasoned technology entrepreneur with an investment banking background. The firm boasts a distinguished team of scientists and engineers committed to positively impacting society. In addition, the company has strong partnerships with leading research and development institutions around the globe.